Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2026-01-01 @ 6:39 PM
Study NCT ID:
NCT05602493
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-09-19
First Post:
2022-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction
Sponsor:
Xeolas Pharmaceuticals Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-22
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-20
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-27
First Submit QC Date:
None
Study First Post Date:
2022-11-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-03
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL